Intercontinental Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.25M Sell
14,155
-1,434
-9% -$123K 0.3% 71
2023
Q1
$1.26M Buy
15,589
+3,457
+28% +$282K 0.32% 66
2022
Q4
$943K Buy
12,132
+72
+0.6% +$5.84K 0.28% 84
2022
Q3
$974K Buy
12,060
+1,571
+15% +$141K 0.31% 81
2022
Q2
$941K Buy
10,489
+2,021
+24% +$205K 0.26% 88
2022
Q1
$940K Buy
8,468
+4,094
+94% +$433K 0.21% 93
2021
Q4
$452K Sell
4,374
-3
-0.1% -$347 0.1% 199
2021
Q3
$549K Sell
4,377
-466
-10% -$60.3K 0.13% 154
2021
Q2
$601K Buy
4,843
+662
+16% +$83.1K 0.12% 158
2021
Q1
$494K Buy
4,181
+564
+16% +$66.1K 0.11% 159
2020
Q4
$424K Buy
+3,617
New +$398K 0.1% 162
2020
Q1
Sell
-625
Closed -$75K 250
2019
Q4
$75K Buy
625
+99
+19% +$10.9K 0.06% 161
2019
Q3
$57K Buy
+526
New +$54.9K 0.04% 206
2019
Q1
Sell
-100
Closed -$9K 446
2018
Q4
$9K Buy
+100
New +$9.35K 0.01% 369

Other funds holding MDT

Intercontinental Wealth Advisors's MDT Position: Q2 2023 in Review

Intercontinental Wealth Advisors reduced its Medtronic (MDT) stake by 9.2% in Q2 2023, selling an estimated $123K and leaving 14,155 shares worth $1.25M. The position accounts for 0.3% of the portfolio, ranked #71.

Intercontinental Wealth Advisors first reported a position in MDT in Q4 2018 and has held it in 14 quarters since. The position peaked at $1.26M in Q1 2023. 2,057 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Intercontinental Wealth Advisors held 14,155 shares of Medtronic worth $1.25M as of Q2 2023.
  • Intercontinental Wealth Advisors sold 1,434 Medtronic shares in Q2 2023, an estimated $123K.
  • Medtronic made up 0.3% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #71 holding.
  • Intercontinental Wealth Advisors first reported a position in Medtronic in Q4 2018 and has held it in 14 quarters since.
  • Intercontinental Wealth Advisors's Medtronic position peaked at $1.26M in Q1 2023.
  • 2,057 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.